Clinical Research Directory
Browse clinical research sites, groups, and studies.
Summary
The TrueLok Elevate Transverse Bone Transport System is a modular external fixation device designed for transverse bone transport. It promotes local vascular and wound healing through controlled corticotomy and gradual distraction. The system is intended for adult patients with bony and/or soft tissuedefects.
Official title: Post-Market Clinical Follow-up Study of the TrueLok Elevate Transverse Bone Transport System for the Treatment of Lower Limb Ulcers as Soft Tissue Defects
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
153
Start Date
2025-11-24
Completion Date
2028-11-24
Last Updated
2026-04-01
Healthy Volunteers
No
Conditions
Interventions
Transverse Bone Transport System
This is a prospective, international, multicentre, observational post-market clinical follow-up (PMCF) study. Adult subjects will be treated according to the manufacturer's Instructions for Use, with follow-up extending to 12 months post-device removal. Participating sites include centres in the US, Europe, the UK, and South Africa. Subjects will be followed using a phased framework: T0: Index Surgery (baseline data, operative details, ulcer status) T1: End of Distraction (device parameters, adverse events, ulcer status) T2: End of Compression (similar to T1) T3: Device Removal (confirmation of union, ulcer status) Post-removal visits: F3: 3 months F6: 6 months F12: 12 months
Locations (5)
Helios Klinikum Wuppertal GmbH
Wuppertal, Germany
General Regional Hospital F. Miulli of Acquaviva delle Fonti
Acquaviva delle Fonti, Bari, Italy
Stellenbosch University
Cape Town, Western Cape, South Africa
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Hull University Teaching Hospitals NHS Trust
Hull, Hull, United Kingdom